Active substanceBeclomethasone + Gentamicin + ClotrimazoleBeclomethasone + Gentamicin + Clotrimazole
Similar drugsTo uncover
  • Candiderm
    cream inwards 
  • Dosage form: & nbsp

    cream for external use

    Composition:

    1 gram of cream contains:

    active substances: clotrimazole - 10.0 mg, beclomethasone dipropionate 0.25 mg, gentamycin sulfate, equivalent to gentamicin-1 mg

    Excipients: propylene glycol, cetomacrogol, petrolatum, paraffin liquid, benzyl alcohol, methyl parahydroxybenzoate (methylparaben), propyl parahydroxybenzoate (propylparaben), butylhydroxytoluene, sodium dihydrogen phosphate monohydrate, sodium hydrophosphate, purified water.

    Description:

    A homogeneous cream of white color.

    Pharmacotherapeutic group:Glucocorticosteroid + antibiotic-aminoglycoside + antifungal agent
    ATX: & nbsp

    D.07   Corticosteroids for the treatment of skin diseases for external use

    D.06.A   Antibiotics for external use

    D.01.A   Antifungal preparations for external use

    Pharmacodynamics:

    Anti-inflammatory, anti-allergic, antibacterial, antifungal.

    Clotrimazole has an antifungal effect due to a violation of the synthesis of ergosterol, which is an integral part of the cell membrane of fungi. Active with respect to; Trichophyton rubrum, Trichophyton mentagrophytes, Epidermophyton floccosum, Microsporum canis, Candida albicans, Malassezia furfur (Pityrosporum orbiculare).

    Beclomethasone has anti-inflammatory, antiallergic, antiexudative and antipruritic effect. It inhibits the accumulation of leukocytes, the release of lysosomal enzymes and mediators of inflammation, inhibits phagocytosis, reduces vascular-tissue permeability, prevents the formation of inflammatory edema.

    Gentamicin- a broad-spectrum antibiotic from the aminoglycoside group, has a bactericidal action against gram-negative bacteria - Pseudomonas aeruginosa, Enterobacter aerogenes, Escherichia coli, Proteus vulgaris, Klebsiella pneumoniae; Gram-positive bacteria: Streptococcus spp., Staphylococcus aureus.

    Pharmacokinetics:

    Pharmacokinetics studies were not conducted.

    Indications:

    - Dermatoses complicated by a secondary infection;

    - epidermophytia of the feet;

    - dermatomycosis (including with localization in the inguinal region), caused by susceptible to the drug pathogens.

    Contraindications:

    Tuberculosis of the skin, cutaneous manifestations of syphilis, chickenpox, herpes simplex, skin reactions after vaccination, hypersensitivity to the components of the drug, children under 7 years old, pregnancy, lactation period, open wounds.

    Dosing and Administration:

    Outwardly. The cream is applied a thin layer on the affected skin areas 2 times a day (morning and evening). The duration of treatment depends on the effectiveness and tolerability of therapy and is, as a rule, 2-4 weeks (no more).

    For children (7-16 years old), the drug is prescribed only strictly according to prescription and under the supervision of a doctor.
    Side effects:

    Burning sensation, hyperemia, erythema, peeling, swelling, dryness, maceration and atrophy of the skin; striae, hypertrichosis, folliculitis, sweating, nettleprostratea, steroid acne, perioral dermatitis, allergic contact dermatitis, telangiectasia, hypopigmentation, pyoderma, furunculosis. With prolonged use, systemic side effects are possible including. oppression of the adrenal cortex function.

    Overdose:

    When exceeding the recommended doses, it is possible to develop symptoms of hypercorticism: weight gain, edema, hypertension, glucosuria, hypokalemia.

    Treatment: symptomatic therapy, if necessary, carry out a correction electrolyte balance. It is recommended to gradually stop the drug.

    Interaction:

    Interactions of the drug with other drugs have not been identified.

    Special instructions:

    Use in Pediatrics

    Children prescribe the drug only under strict indications and under medical supervision, as it is possible to develop systemic side effects associated with beclomethasone. When applying the drug on large surfaces and / or under an occlusive dressing, it is possible to suppress the function of the hypothalamic-pituitary-adrenal system and the development of symptoms of hypercorticism, a decrease in the excretion of growth hormone, an increase in intracranial pressure may be observed.

    The drug is not used in ophthalmology. Do not apply to the skin in the eye area. With a view toyshethe The effectiveness of therapy is possible using occlusive dressings. It should be taken into account that transdermal absorption of beclomethasone and gentamicin increases, which leads to an increased risk of systemic side effects.

    When developing a stable bacterial or fungal microflora, discontinue the use of the drug and prescribe appropriate therapy. It is possible to develop cross-resistance with aminoglycoside antibiotics.

    Form release / dosage:
    Cream for external use.
    Packaging:For 15 g and 30 g in an aluminum tube with a lid having a point for piercing. Each tube together with instructions for medical use is placed in a cardboard box.
    Storage conditions:

    In the dark place at a temperature of no higher than 25 ° C. Do not freeze.

    Keep out of the reach of children.

    Shelf life:

    3 years. Do not use after the expiration date.

    Terms of leave from pharmacies:On prescription
    Registration number:LSR-002530/08
    Date of registration:04.04.2008 / 17.01.2013
    Expiration Date:Unlimited
    The owner of the registration certificate:Glenmark Pharmaceuticals Co., Ltd.Glenmark Pharmaceuticals Co., Ltd. India
    Manufacturer: & nbsp
    Representation: & nbspGLENMARK PHARMACEUTICALS LTD. GLENMARK PHARMACEUTICALS LTD. India
    Information update date: & nbsp21.11.2017
    Illustrated instructions
      Instructions
      Up